Key result
Anti-allergic therapy rapidly resolves transient ST-elevation triggered by anti-snake venom administration.
Why the study?
Kounis syndrome is an acute coronary syndrome associated with a hypersensitivity reaction, and snake envenomation and antisnake venom administration have been reported as possible triggers in isolated cases.
Case Report (n=1)
No
Clinicians should consider Kounis syndrome alongside direct venom-induced myocardial injury in snakebite patients who develop acute chest pain and ST-segment elevation during or after anti-snake venom administration, while recognizing that adrenaline remains first-line therapy for anaphylaxis under close cardiac monitoring.
Answers are grounded in this paper and cite their sources.
Supports vigilance for Kounis syndrome during anti-snake venom; case report extends sparse triggers but remains hypothesis-generating.
Kounis syndrome is an acute coronary syndrome associated with a hypersensitivity reaction, potentially involving mast-cell mediator release and coronary vasomotor dysfunction.Snake envenomation and antisnake venom (ASV) administration have been reported as possible triggers in isolated cases.We report a 55-year-old man with hypertension and type 2 diabetes mellitus who presented approximately three hours after a suspected viper bite to the right ankle with a prolonged whole blood clotting time (WBCT) (>20 minutes) and received 10 vials of ASV.Shortly after ASV administration, he developed chest pain, palpitations, and breathlessness with ST-segment elevation in leads I, augmented vector left (aVL), and V2-V3 and reciprocal ST depression in leads II, III, and augmented vector foot (aVF), together with elevated troponin-T and creatine kinase-MB (CK-MB).The ECG changes resolved within 10 minutes of treatment with adrenaline, hydrocortisone, and pheniramine.Echocardiography showed a hypokinetic infero-posterior wall with an ejection fraction of 45-50% and indeterminate chronicity, and coronary angiography performed after stabilization showed normal epicardial coronary arteries.Kounis syndrome, provisionally type I, is one possible explanation, alongside direct venom-induced myocardial injury and other causes of myocardial injury; the diagnosis remains suspect because venom and ASV could not be distinguished as triggers and alternative causes cannot be fully excluded.Clinicians should consider Kounis syndrome in snake-bite patients with chest pain during or after ASV administration, while recognizing that adrenaline remains first-line treatment for anaphylaxis and should be given with cardiac monitoring.
No takes yet. Share an insight, caveat, or question.
Wankhade et al. (2026) conducted a case report in Suspected Kounis syndrome following snake envenomation and anti-snake venom administration (n=1). Snake envenomation and anti-snake venom (ASV) followed by adrenaline, hydrocortisone, and pheniramine was evaluated on Resolution of transient ST-segment elevation and hypersensitivity symptoms. Anti-snake venom administration after a viper bite was followed within 20 minutes by transient ST-elevation that resolved within 10 minutes of anti-allergic therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: